RPG Life Sciences Q2 Results FY27: Revenue Climbs 16.49% to Rs 211.64 Cr, PAT Falls to Rs 28.22 Cr
- October 29, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
RPG Life Sciences Q2 Results FY27 were declared on 29 October 2026 for the July to September 2026 quarter. On a consolidated basis, revenue rose 16.49% YoY to Rs 211.64 Cr, while net profit fell 23.42% to Rs 28.22 Cr from Rs 36.85 Cr. Operating Profit edged up 3.56% to Rs 40.42 Cr. These quarterly results show solid YoY growth in sales but a lower bottom line.
RPG Life Sciences Ltd (RPGLIFE) Q2 Results FY27 announced on 29 October 2026, covering the company’s financial performance for the July to September quarter. The results date brought consolidated revenue of Rs 211.64 Cr and PAT of Rs 28.22 Cr. The detail in RPG Life Sciences Q2 Results FY27 explains how sales growth and a lower profit sat side by side in the quarter.
This RPG Life Sciences Q2 Results results analysis covers the financial highlights, the business drivers named in the disclosed data, the outlook and the risks. Univest has set out the consolidated results in the same order an investor would read them, starting with the Financial Highlights table below.
Click Here – Get Free Investment Predictions
RPG Life Sciences Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 211.64 Cr | Rs 181.68 Cr | +16.49% YoY |
| Operating Profit | Rs 40.42 Cr | Rs 39.03 Cr | +3.56% YoY |
| Net Profit (PAT) | Rs 28.22 Cr | Rs 36.85 Cr | -23.42% YoY |
Source: company filing for RPG Life Sciences Q2 Results FY27, 29 October 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from RPG Life Sciences Q2 Results: What Stands Out
- Revenue of Rs 211.64 Cr grew 16.49% YoY from Rs 181.68 Cr, the clearest piece of YoY growth in the quarter.
- Net profit of Rs 28.22 Cr fell 23.42% from Rs 36.85 Cr, so RPG Life Sciences Q2 Results FY27 show profit moving against revenue.
- Operating Profit of Rs 40.42 Cr rose 3.56% YoY from Rs 39.03 Cr, a modest gain next to the sales increase.
- Net profit margin narrowed to 13.3% from 20.3% in the comparison quarter, which sits behind the lower net profit.
- Net profit was down 7.7% from Rs 30.58 Cr in the previous quarter, and the next section reads the numbers in more detail.
RPG Life Sciences Q2 Results FY27: Performance Analysis
Revenue grew while profit contracted. Revenue for the quarter stood at Rs 211.64 Cr against Rs 181.68 Cr a year earlier, a rise of 16.49%, while net profit slid to Rs 28.22 Cr, a fall of 23.42%. That split is the central fact of RPG Life Sciences Q2 Results FY27.
Operating Profit moved from Rs 39.03 Cr to Rs 40.42 Cr, an increase of 3.56%. Since revenue rose far faster than Operating Profit, the RPG Life Sciences Q2 Results results analysis shows that the extra sales did not carry through to the lower profit lines at the same pace. The supplied data confirms the numbers but does not establish the specific cause.
The quarterly results also show the gap between the top line and the bottom line in margin terms. Net profit margin came in at 13.3% against 20.3% a year ago. Investors tracking YoY growth will want to watch whether later disclosures narrow that gap, which is where the analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The quarterly results point first to sales. Revenue grew 16.5% year on year to Rs 211.64 Cr in the latest quarter, and RPG Life Sciences Q2 Results FY27 record this as the main positive in the disclosed data.
Return Ratios – Return on equity was 20.28% in FY26 and return on capital employed was 26.99% in FY26. These are the latest full-year ratios supplied, and they describe how efficiently the company used the capital it holds.
Balance Sheet Strength – The company is almost debt free, with a debt-to-assets ratio of 0.03 in FY26. A low debt level means the lower net profit this quarter is not linked to a heavy borrowing load in the supplied data.
FY27 Outlook After RPG Life Sciences Q2 Results
The RPG Life Sciences Q2 Results results analysis does not come with management guidance in the supplied data, so this section stays with what the figures show. A 16.49% rise in revenue sits against a 23.42% fall in net profit, and the full FY27 picture will depend on how the remaining quarters balance the two.
Net profit of Rs 28.22 Cr is lower than both the Rs 36.85 Cr of the year-ago quarter and the Rs 30.58 Cr of the previous quarter. FY27 full-year results will therefore depend on subsequent quarters and on conditions disclosed by the company in later filings, which brings the focus to the risks.
Key Risks to Watch After RPG Life Sciences Q2 Results FY27
Lower Net Profit
Net profit fell 23.4% year on year to Rs 28.22 Cr. After RPG Life Sciences Q2 Results FY27, this is the headline risk, because profit moved down even as revenue moved up over the same period.
Narrower Net Margin
Net profit margin narrowed to 13.3% from 20.3% in the comparison quarter. A smaller share of each rupee of revenue reaching profit is the second point to follow in the next set of YoY growth figures.
Sequential Decline
Net profit was down 7.7% quarter on quarter from Rs 30.58 Cr. Two lower comparisons in a row make the sequential trend something investors may want to follow alongside the Univest Screener.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
RPG Life Sciences Q2 Results FY27 show Consolidated revenue of Rs 211.64 Cr, up 16.49% YoY, and net profit of Rs 28.22 Cr, down 23.42%. The quarterly results give a mixed picture, and the consolidated results are best read together with the table above. Investors should consult a SEBI-registered advisor before acting. For this RPG Life Sciences Q2 Results, the Univest app lists the same figures.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on RPG Life Sciences Q2 Results FY27
What are RPG Life Sciences Q2 Results FY27?
Ans. RPG Life Sciences Q2 Results FY27 are the consolidated quarterly results for July to September 2026, declared on 29 October 2026. Alongside this, they pair 16.49% revenue growth with a lower net profit, as the Financial Highlights table shows.
What is the results date for RPG Life Sciences Q2 Results FY27?
Ans. The results date for RPG Life Sciences Q2 Results FY27 is 29 October 2026, when figures for the July to September 2026 quarter were declared. This is also the date used in the Quick Answer box.
What revenue was reported in RPG Life Sciences Q2 Results FY27?
Ans. RPG Life Sciences Q2 Results FY27 report revenue of Rs 211.64 Cr, compared with Rs 181.68 Cr a year earlier. That is a rise of 16.49%, which the Performance Analysis section covers in more detail.
What net profit was reported in RPG Life Sciences Q2 Results FY27?
Ans. RPG Life Sciences reported net profit of Rs 28.22 Cr in RPG Life Sciences Q2 Results FY27, against Rs 36.85 Cr in the year-ago quarter. Compared with that base, the fall of 23.42% is explained in the Key Takeaways.
How much YoY growth did revenue show in RPG Life Sciences Q2 Results FY27?
Ans. Revenue showed YoY growth of 16.49% in RPG Life Sciences Q2 Results FY27, moving from Rs 181.68 Cr to Rs 211.64 Cr. Alongside this, net profit moved the other way, so growth was not shared by every line.
Did net profit rise or fall in RPG Life Sciences Q2 Results?
Ans. Net profit fell in RPG Life Sciences Q2 Results, down 23.42% YoY to Rs 28.22 Cr from Rs 36.85 Cr. This means profit declined even though revenue grew, as the Performance Analysis section explains.
What was the Operating Profit in RPG Life Sciences Q2 Results FY27?
Ans. Operating Profit in RPG Life Sciences Q2 Results FY27 was Rs 40.42 Cr, up 3.56% from Rs 39.03 Cr a year earlier. While this is a gain, it is smaller than the revenue growth shown in the Financial Highlights.
Are RPG Life Sciences Q2 Results consolidated results or standalone results?
Ans. The figures in RPG Life Sciences Q2 Results are consolidated results, covering RPG Life Sciences Ltd on a consolidated basis. This is why revenue of Rs 211.64 Cr is the number to use across every section of this article.
What business factors shaped RPG Life Sciences Q2 Results FY27?
Ans. The disclosed factors for RPG Life Sciences Q2 Results FY27 are revenue growth of 16.5%, return on equity of 20.28% and return on capital employed of 26.99%. Alongside these, the debt-to-assets ratio was 0.03 in FY26.
What are the key risks after RPG Life Sciences Q2 Results FY27?
Ans. The key risks after RPG Life Sciences Q2 Results FY27 are a 23.4% YoY fall in net profit, a narrower net margin of 13.3%, and a 7.7% quarterly decline. These three points are laid out in the Key Risks section.
What is the outlook after RPG Life Sciences Q2 Results?
Ans. No management guidance is supplied after RPG Life Sciences Q2 Results, so FY27 depends on later quarters and company disclosures. This means the results analysis stays with the figures, as the Outlook section explains.
Where can I find the complete RPG Life Sciences Q2 Results FY27 data?
Ans. The complete RPG Life Sciences Q2 Results FY27 data is on the Univest stock page for RPG Life Sciences and in the Financial Highlights table above. Alongside this, the Univest Screener lets you compare the quarter with other companies.
